CDER’s work with foreign stakeholders enables progress in the harmonization of scientific and technical standards and regulatory requirements among regulatory authorities.
Similar Posts
FDA’s ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience
FDA’s Center for Drug Evaluation and Research (CDER) recently accepted a new submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program. This submission is the first artificial intelligence-based and digital health technology-based project and the first proMobile Power Unit AC Power Cord Recall: Abbott Medical Removes AC Power Cord Associated with HeartMate Mobile Power Unit (MPU) Due to Potential Risk of the Cord Not Locking into Place
Abbott Medical is removing power cords associated with the HeartMate Mobile Power Unit due to a potential risk of the cord not locking into place.First and Last Bakery, LLC Recalls First and Last Brand Tomato Sauce Products Because Of Possible Health Risk
First and Last Bakery, LLC of Hartford, CT, is recalling the following products due to a possible health risk identified by the Connecticut Department of Consumer Protection.
• First and Last Original Marinara Sauce, Tomato & Basil
• First and Last Original Traditional Pasta Sauce, Meat FlavoredPublic Meeting on the Reauthorization of Generic Drug User Fee Amendments (GDUFA) – 07/11/2025
FDA is announcing a public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments for fiscal years 2028 through 2032.FDA Provides Guidance on Remote Interactive Evaluations for Oversight of Drug Facilities During COVID-19
FDA releases guidance on how remote interactive evaluations will be requested by FDA and conducted for the duration of COVID-19 at drug facilities.C3TI Demonstration Program Proposal Submission
Submitting content and format of the C3TI Demonstration Program Proposal